These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3713924)

  • 41. Evaluation of the antitumor efficacy of the somatostatin structural derivative TT-232 on different tumor models.
    Tejeda M; Gaál D; Hullán L; Hegymegi-Barakonyi B; Kéri G
    Anticancer Res; 2006; 26(5A):3477-83. PubMed ID: 17094470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Morphological damage induced in vivo by Lonidamine on human metastatic cancer cells.
    De Martino C; Battelli T; Cavaliere R; Gallo Curcio C; Bellocci M; Manocchi D; Giustini L; Mattioli R; Rinaldi M; Di Filippo F
    Oncology; 1984; 41 Suppl 1():94-103. PubMed ID: 6717904
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lonidamine and hyperthermia: clinical experience in melanoma. Preliminary results.
    Cavaliere R; Di Filippo F; Varanese A; Carlini S; Calabro A; Aloe L; Piarulli L
    Oncology; 1984; 41 Suppl 1():116-20. PubMed ID: 6717890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Study.
    Band PR; Maroun J; Pritchard K; Stewart D; Coppin CM; Wilson K; Eisenhauer EA
    Cancer Treat Rep; 1986 Nov; 70(11):1305-10. PubMed ID: 3768873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
    Ganapathi R; Reiter W; Krishan A
    J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [In vitro studies of DNA synthesis inhibition by hyperthermia (42.5 degrees C, 120 min) and cytostatic drugs in embryonal tumors and sarcomas in childhood].
    Willnow U; Dumon K
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():1100-1. PubMed ID: 9101790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New substances with cytotoxic and antitumor effects. IV. In vitro effect of some veratrum alkaloids and their derivatives on leukemia P388 cells.
    Fuska J; Fusková A; Vassová A; Votický Z
    Neoplasma; 1981; 28(6):709-14. PubMed ID: 7339499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of Dex-Verapamil on Doxorubicin cytotoxicity in P388 murine leukemia cells.
    Noviello E; Allievi E; Russo P; Parodi S
    Anticancer Drug Des; 1997 Jun; 12(4):261-76. PubMed ID: 9199659
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
    Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
    Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Arrhenius relationships from the molecule and cell to the clinic.
    Dewey WC
    Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
    Tsuruo T; Oh-Hara T; Sudo Y; Naito M
    Anticancer Res; 1993; 13(2):357-61. PubMed ID: 8517647
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models.
    Mirabelli CK; Johnson RK; Sung CM; Faucette L; Muirhead K; Crooke ST
    Cancer Res; 1985 Jan; 45(1):32-9. PubMed ID: 3917372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug resistance studies on intraspecific hybridomas.
    Pályi I; Turi G; Szikla K; Dallmann L
    Arch Geschwulstforsch; 1981; 51(1):119-24. PubMed ID: 7259434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
    Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
    Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potentiation of cisplatin cytotoxicity by lonidamine in primary cultures of human ovarian cancer.
    Orlandi L; Zaffaroni N; Gornati D; Veneroni S; Silvestrini R
    Anticancer Res; 1994; 14(3A):1161-4. PubMed ID: 8074467
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic potency of transduction with herpes simplex virus thymidine kinase gene against multidrug resistant mouse leukemia cells.
    Takenaga K; Tagawa M; Sakiyama S
    Anticancer Res; 1996; 16(2):681-5. PubMed ID: 8687114
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
    Masunaga S; Ono K; Hori H; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Kasai S; Nagasawa H; Uto Y
    Radiat Med; 1998; 16(6):441-8. PubMed ID: 9929144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lonidamine-induced, pH dependent inhibition of cellular oxygen utilization.
    Stryker JA; Gerweck LE
    Radiat Res; 1988 Feb; 113(2):356-61. PubMed ID: 3340739
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Potentiating effect of disodium salt of 2,6-dimethyl-1,4-dihydropyridine-3,5-bis-carbonyl hydroxyacetic acid on the activity of various antitumor agents].
    Zidermane AA; Dauvarte AZh; Kozhukhov AN; Meĭrena DV; Neĭmane DU
    Eksp Onkol; 1987; 9(2):50-2. PubMed ID: 3582240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.